F500 Pharma & Biotech · Pharmaceuticals · No confirmed finding (unverified, not clean)
Pfizer
Headline
Nothing confirmed
Nothing company-specific confirmed this pass on consumer data.
Not independently verified. Verification status: Unverified - heuristic first draft. Publish state: draft unverified.
What this pass recorded. Nothing company-specific confirmed this pass on consumer data. The structural finding across this entire tab is worth stating once here: pharmaceutical manufacturers generally have no direct consumer relationship - your prescription runs through a prescriber, a PBM and a pharmacy - so they collect relatively little from you directly while nonetheless holding substantial patient-level data through clinical trials, patient support programmes and purchased datasets. The absence of a consumer contract is not the absence of a data relationship; it is the absence of a consumer-facing document that would disclose it.
- Severity
- Evidence tierUnassigned
- Claims confirmed
- Last verified2026-08-04
Primary source. None recorded — Unverified - heuristic first draft.
Terms
Arbitration
Not independently confirmed this pass — standard binding arbitration + class action waiver expected.
Data sharing
Not independently confirmed this pass with a company-specific consumer data lawsuit beyond the shared industry findings below. SHARED FINDING ACROSS MANY PHARMA COMPANIES: (1) A 2024 breach at CENCORA (a major pharmaceutical distributor, documented separately in the Healthcare Providers tab of this tracker) exposed patient information — names, addresses, birthdates, health diagnoses, and prescriptions — for patients of more than a dozen manufacturers (reportedly including Bayer, Genentech, AbbVie, Novartis, Regeneron and GSK) whose programmes ran through Cencora; whether Pfizer patients were affected was not verified this pass. (2) A SEPARATE 2026 lawsuit (Illinois, under the state's Genetic Information Privacy Act; status not re-verified Oct 2026) alleges Tempus AI obtained Ambry Genetics' customer GENETIC data through its 2025 acquisition without the written consent the Act requires, used it to train AI models, and sells access to pharmaceutical companies; the coverage reviewed names no specific pharma partner (Pfizer is not named), and a reported CFO 'record year' remark was not verified.
Fees and billing
Not itemized this pass.
Contacts
Privacy contact. Not recorded.
Legal notice. Not verified this pass. If publicly traded: SEC Form 10-K cover page gives the official corporate address; the Secretary of State business-entity search in the state of incorporation gives the registered agent, which must accept service. If private: the state registered agent is usually the only reliable route.
Mailing address. Not recorded.
Evidence
No claims have been itemized for this row yet.
No sources are on file for this row yet.
Source vault
Link status: Candidate - not yet fetched
| Document | Last fetch | |
|---|---|---|
| Privacy policy See Pfizer's own published privacy policy | Not fetched yet | NOT CONFIRMED |
| Terms of service See Pfizer's own published terms of service | Not fetched yet | NOT CONFIRMED |
| Website No URL recorded | Not fetched yet | — |
| Primary source No URL recorded Verification: Unverified - heuristic first draft | Not fetched yet | — |
Enforcement
No enforcement actions are linked to this row.
State statute
No HQ state on file, so no state statute applies by headquarters.